Head to head

I2PL vs OptiLIGHT (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: No new-price range is on file for either I2PL or OptiLIGHT. Request current quotes to compare purchase costs.
Practice fit: Both are listed under IPL platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL platform

View full device profile →

Device B

IPL platform

View full device profile →

Price comparison

Price comparison: Ellipse I2PL / MultiFlex+ vs Lumenis OptiLIGHT
Attribute	Ellipse I2PL / MultiFlex+	Lumenis OptiLIGHT
New price range	Not published	Not published
Used asking range	$8k–$18kSource not documented	Not published
Payback calculator	View ROI calculator	View cost details
Next step	Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Ellipse I2PL / MultiFlex+: Not published
Lumenis OptiLIGHT: Not published

Used asking range

Ellipse I2PL / MultiFlex+: $8k–$18kSource not documented
Lumenis OptiLIGHT: Not published

Payback calculator

Ellipse I2PL / MultiFlex+: View ROI calculator
Lumenis OptiLIGHT: View cost details

Next step

Ellipse I2PL / MultiFlex+

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Lumenis OptiLIGHT

Consumable economics

Consumable economics: Ellipse I2PL / MultiFlex+ vs Lumenis OptiLIGHT
Attribute	Ellipse I2PL / MultiFlex+	Lumenis OptiLIGHT
Consumable cost / lock-in	—	—
Service cost	Not published	Not published

Consumable cost / lock-in

Ellipse I2PL / MultiFlex+: —
Lumenis OptiLIGHT: —

Service cost

Ellipse I2PL / MultiFlex+: Not published
Lumenis OptiLIGHT: Not published

FDA clearance

FDA clearance: Ellipse I2PL / MultiFlex+ vs Lumenis OptiLIGHT
Attribute	Ellipse I2PL / MultiFlex+	Lumenis OptiLIGHT
FDA status & indication	FDA ClearedK060516, K043255, K081408, K140670 Read FDA indication wording “Ellipse I2PL The Intended Use for Ellipse 12PL is: Ellipse l'PL is intended for use in dermatology: a Hair removal (permanent hair reduction). * Treatment of benign pigmented lesions (including, but not limited to solar lentigines, ephilides, mottled pigmentation) and benign vascular lesions (including but not limited to diffuse redness, telangiectasias, port wine stains). * Treatment of inflammatory acne. The Indications for Use for Ellipse PPL are: Application Treatment Variable Fitzpatrick Skin Typ" Hair Removal HR Applicator Hair (Thin, Normal, Thick) , 1 1 1 1/ HR-S Applicator Hair Removal IlHair (Thin, Nonlal, Thick) I/ 1 1 1 1 HR-D Applicator Treatment of Benign Pigmented Lesions Pigmentation / Vessel Size , 1 & & and Benign Vascular Lesions Treatment of Telangiectasias Vessel size (Thin, medium, thick) . . .”	FDA ClearedDe Novo: DEN200028, K193500 Read FDA indication wording “Universal IPL with a spectrum of 400-1200nm (with different filters) is indicated for: Improvement of signs of Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye, in patients 22 years of age and older with moderate to severe signs and symptoms of DED due to MGD and with Fitzpatrick skin types I-IV. IPL is to be applied only to skin on the malar region of the face, from tragus to tragus including the nose (eyes should be fully covered by protective eyewear). IPL is intended to be applied as an adjunct to other modalities, such as meibomian gland expression, artificial tear lubricants and warm compresses.”

FDA status & indication

Ellipse I2PL / MultiFlex+: FDA ClearedK060516, K043255, K081408, K140670
Read FDA indication wording
“Ellipse I2PL The Intended Use for Ellipse 12PL is: Ellipse l'PL is intended for use in dermatology: a Hair removal (permanent hair reduction). * Treatment of benign pigmented lesions (including, but not limited to solar lentigines, ephilides, mottled pigmentation) and benign vascular lesions (including but not limited to diffuse redness, telangiectasias, port wine stains). * Treatment of inflammatory acne. The Indications for Use for Ellipse PPL are: Application Treatment Variable Fitzpatrick Skin Typ" Hair Removal HR Applicator Hair (Thin, Normal, Thick) , 1 1 1 1/ HR-S Applicator Hair Removal IlHair (Thin, Nonlal, Thick) I/ 1 1 1 1 HR-D Applicator Treatment of Benign Pigmented Lesions Pigmentation / Vessel Size , 1 & & and Benign Vascular Lesions Treatment of Telangiectasias Vessel size (Thin, medium, thick) . . .”
Lumenis OptiLIGHT: FDA ClearedDe Novo: DEN200028, K193500
Read FDA indication wording
“Universal IPL with a spectrum of 400-1200nm (with different filters) is indicated for: Improvement of signs of Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye, in patients 22 years of age and older with moderate to severe signs and symptoms of DED due to MGD and with Fitzpatrick skin types I-IV. IPL is to be applied only to skin on the malar region of the face, from tragus to tragus including the nose (eyes should be fully covered by protective eyewear). IPL is intended to be applied as an adjunct to other modalities, such as meibomian gland expression, artificial tear lubricants and warm compresses.”

Which chains run each

Which chains run each: Ellipse I2PL / MultiFlex+ vs Lumenis OptiLIGHT
Attribute	Ellipse I2PL / MultiFlex+	Lumenis OptiLIGHT
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Ellipse I2PL / MultiFlex+: 0 recorded pairings
Lumenis OptiLIGHT: 0 recorded pairings

Chains using it

Ellipse I2PL / MultiFlex+: —
Lumenis OptiLIGHT: —

Approved reviews

Ellipse I2PL / MultiFlex+: 0
Lumenis OptiLIGHT: 0

Specs and platform

Specs and platform: Ellipse I2PL / MultiFlex+ vs Lumenis OptiLIGHT
Attribute	Ellipse I2PL / MultiFlex+	Lumenis OptiLIGHT
Manufacturer	Ellipse	Lumenis
Built by (OEM)	Ellipse A/S	Lumenis Be Ltd.
Category	IPL platform	IPL platform
Technology	Dual-mode filtered IPL (IPL)	Optimal Pulse Technology IPL (IPL)
Launch year	2006	—
Status	Legacy-used-market	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Ellipse I2PL / MultiFlex+: Ellipse
Lumenis OptiLIGHT: Lumenis

Built by (OEM)

Ellipse I2PL / MultiFlex+: Ellipse A/S
Lumenis OptiLIGHT: Lumenis Be Ltd.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cutera Xeo

Multi-app platform

New: $80k–$120k

Cutera Excel HR

Dual-wavelength laser

New: $95k–$135k

InMode Triton

Triple-wavelength diode

New: $100k–$135k

Cynosure Elite iQ

Dual-wavelength platform

New: $85k–$115k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.